CSM Technologies Limited has officially confirmed that there has been no deviation or variation in the utilization of funds raised from its Initial Public Offering (IPO) for the quarter ended September 30, 2026. The company has submitted a statement to the BSE and NSE, adhering to SEBI regulations. The total funds raised amounted to INR 145.78 crore, with INR 130.51 crore utilized as of the reporting date.
IPO Fund Utilization Update for Q2 2026
CSM Technologies Limited has formally communicated its compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by confirming that there has been no deviation or variation in the utilization of its Initial Public Offering (IPO) proceeds for the quarter that concluded on September 30, 2026. This disclosure was made to both the BSE Limited and the National Stock Exchange of India Limited.
Financial Overview of Fund Utilization
The company’s IPO raised a total of INR 145.78 crore. For the quarter ended September 30, 2026, the total funds utilized amounted to INR 130.51 crore. This figure aligns with the allocated purposes as outlined in the company’s fundraising documentation.
Breakdown of Fund Allocation and Utilization
The statement provides a detailed breakdown of how the IPO funds were allocated and utilized across various objectives:
- Funding capital requirements of the Company: Original Allocation: INR 56.00 crore; Funds Utilised: INR 56.00 crore.
- Repayment or prepayment of outstanding borrowings: Original Allocation: INR 22.63 crore; Funds Utilised: INR 21.72 crore.
- Achieving inorganic growth through acquisitions and strategic initiatives: Original Allocation: INR 50.16 crore; Funds Utilised: INR 36.21 crore.
- Issue related expenses: Original Allocation: INR 17.00 crore; Funds Utilised: INR 16.58 crore.
The total original allocation for these purposes was INR 145.78 crore, with a total of INR 130.51 crore utilized by the end of the quarter.
Regulatory Compliance
The company has enclosed a statement to this effect, ensuring transparency and adherence to the stipulated regulatory requirements. The Audit Committee and external auditors have reviewed the matter and provided their comments, which were noted as ‘None’ in the provided annexure, indicating no adverse findings.
Source: BSE
